Concepedia

James Tartaglia

JT

Statistics

Publications

94

Citations

8.4K

H-Index

52

Active since

1985

Affiliations

Reprogenetics(Current)

Sanofi (United States)

Duke Medical Center

Armed Forces Research Institute of Medical Science

National Cancer Institute

James Tartaglia is an author at Reprogenetics specializing in immunology, infectious diseases, and vaccinology.

Publications per year

1985–2022

94

Publications

94

NYVAC: A highly attenuated strain of vaccinia virus

James Tartaglia, Marion E. Perkus, J TAYLOR et al. · Virology · 1992 · 471 citations

, , +9

Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination

Nicole L. Yates, Hua-Xin Liao, Youyi Fong et al. · Science Translational Medicine · 2014 · 454 citations

, , +17

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Hua-Xin Liao, Mattia Bonsignori, S. Munir Alam et al. · Immunity · 2013 · 386 citations · Full text

, , +15

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

Alexandre Harari, Pierre‐Alexandre Bart, Wolfgang Stöhr et al. · The Journal of Experimental Medicine · 2008 · 294 citations · Full text

, , +17

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials

David C. Montefiori, Chitraporn Karnasuta, Yunda Huang et al. · The Journal of Infectious Diseases · 2012 · 284 citations · Full text

, , +17

1–5 of 94